SCYNEXIS Appoints Dr. Steven K. Burke to Board of Directors
SCYNEXIS appointed Dr. Steven K. Burke, an expert in chronic kidney disease, to its Board of Directors on September 18, 2026. The addition of Burke's extensive development expertise is expected to support the company’s clinical progress and strategic goals.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed